Baxter Recalls Buretrol IV Products Over Air Leakage Risk

Law360, New York (November 9, 2012, 4:01 PM EST) -- Baxter Healthcare Corp. has initiated a voluntary recall of its Buretrol intravenous solution sets because of a potentially defective ball-valve feature that may allow air into a patient’s bloodstream, the U.S. Food and Drug Administration said Thursday.

“Baxter has determined that the ball-valve component is allowing air to flow past the valve and enter the tubing once the pre-measured amount of fluids is completely administered to the patient,” the FDA said in a statement.

If the air is not removed, the air present in the tubing...
To view the full article, register now.